Recombinant bacteriophage lysins as antibacterials

References

• Bergh O, Borsheim KY, Bratbak G, Heldal M. High abundance of viruses found in aquatic environments. Nature 1989; 340:467 - 468
   PubMed Web of Science ®Google Scholar
• Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 1998; 95:6578 - 6583
   PubMed Web of Science ®Google Scholar
• d'Herelle FH. Sur un microbe invisible antagoniste des bacilles dysenteriques. C R Acad Sci Gen 1917; 165:373 - 375
   Google Scholar
• Hankin EH. L'action bactericide des eaux de la jumna et du gange sur le vibrion du cholera. Ann Inst Pasteur 1896; 10:511
   Google Scholar
• Twort FW. An investigation on the nature of ultramicroscopic viruses. Lancet 1915; 1241 - 1246
   Google Scholar
• Hermoso JA, Garcia JL, Garcia P. Taking aim on bacterial pathogens. Curr Opin Microbiol 2007; 10:461 - 472
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520 - 532
   PubMed Web of Science ®Google Scholar
• Infectious Diseases Society of America (IDSA). Bad bugs, no drugs. As antibiotic discovery stagnates…a public health crisis brews 2004; 1 - 35
   Google Scholar
• Russel M, Linderoth NA, Sali A. Filamentous phage assembly: variation on a protein export theme. Gene 1997; 192:23 - 32
   PubMed Web of Science ®Google Scholar
• Borysowski J, Weber-Dabrowska B, Gorski A. Bacteriophage endolysins as a novel class of antibacterial agent. Exp Biol Med 2006; 231:366 - 377
   PubMed Web of Science ®Google Scholar
• Young R. Bacteriophage lysis: mechanism and regulation. Microbiol Rev 1992; 56:430 - 481
   PubMedGoogle Scholar
• Wang IN, Deaton J, Young R. Holins: the protein clocks of bacterial infection. Annu Rev Microbiol 2000; 54:799 - 825
   PubMed Web of Science ®Google Scholar
• Young R, Blasi U. Holins: form and function in bacteriophage lysis. FEMS Microbiol Rev 1995; 17:191 - 205
   PubMed Web of Science ®Google Scholar
• Loessner MJ. Bacteriophage endolysins-current state of research and applications. Curr Opin Microbiol 2005; 8:480 - 487
   PubMed Web of Science ®Google Scholar
• Loessner MJ, Schneider A, Scherer S. A new procedure for efficient recovery of DNA, RNA and proteins from Listeria cells by rapid lysis with a recombinant bacteriophage endolysin. Appl Environ Microbiol 1995; 61:1150 - 1152
   PubMed Web of Science ®Google Scholar
• Nelson D, Loomis L, Fischetti VA. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 2001; 98:4107 - 4112
   PubMed Web of Science ®Google Scholar
• Loeffler JM, Nelson D, Fischetti VA. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 2001; 294:2170 - 2172
   PubMed Web of Science ®Google Scholar
• Schuch R, Nelson D, Fischetti VA. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 2002; 418:884 - 889
   PubMed Web of Science ®Google Scholar
• Zimmer M, Vukov N, Scherer S, Loessner MJ. The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl Environ Microbiol 2002; 68:5311 - 5317
   PubMed Web of Science ®Google Scholar
• O'Flaherty S, Coffey A, Meaney W, Fitzgerald GF, Ross RP. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 2005; 187:7161 - 7164
   PubMed Web of Science ®Google Scholar
• Loessner MJ, Maier SK, Daubek-Puza H, Windlinger G, Scherer S. Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J Bacteriol 1997; 179:2845 - 2851
   PubMed Web of Science ®Google Scholar
• Yoong P, Schuch R, Nelson D, Fischetti VA. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J Bacteriol 2004; 186:4808 - 4812
   PubMed Web of Science ®Google Scholar
• Kunin CM. Resistance to antimicrobial drugs—a worldwide calamity. Ann Intern Med 1993; 18:557 - 561
   Google Scholar
• Neu HC. The crisis in antibiotic resistance. Science 1992; 257:1064 - 1073
   PubMed Web of Science ®Google Scholar
• European Antimicrobial Resistance Surveillance system. EARSS Annual Report 2005–2006 1 - 47
   Google Scholar
• Diaz E, Lopez R, Garcia JL. Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. Proc Natl Acad Sci USA 1990; 87:8125 - 8129
   PubMed Web of Science ®Google Scholar
• Garcia P, Garcia JL, Garcia E, Sanchez-Puelles JM, Lopez R. Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene 1990; 86:81 - 88
   PubMed Web of Science ®Google Scholar
• Fischetti VA. Kutter E, Sulakvelidze A. The use of phage lytic enzymes to control bacterial infections. Bacteriophages: Biology and Applications 2004; Boca Raton CRC Press 321 - 334
   Google Scholar
• Loessner MJ, Kramer K, Ebel F, Scherer S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol Microbiol 2002; 44:335 - 349
   PubMed Web of Science ®Google Scholar
• Lopez R, Garcia E. Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes and bacteriophage. FEMS Microbiol Rev 2004; 28:553 - 580
   PubMed Web of Science ®Google Scholar
• Fischetti VA. Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol 2008; 11:393 - 400
   PubMed Web of Science ®Google Scholar
• Navarre WW, Ton-That H, Faull KF, Schneewind O. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem 1999; 274:15847 - 15856
   PubMed Web of Science ®Google Scholar
• Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage ΦMR11. J Infect Dis 2007; 196:1237 - 1247
   PubMed Web of Science ®Google Scholar
• Nelson D, Schuch R, Cahales P, Zhu S, Fischetti VA. PlyC: A multimeric bacteriophage lysin. Proc Natl Acad Sci USA 2006; 103:10765 - 10770
   PubMed Web of Science ®Google Scholar
• Hermoso JA, Monterroso B, Albert A, Galan B, Ahrazem O, Garcia P, et al. Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1. Structure 2003; 11:1239 - 1249
   PubMed Web of Science ®Google Scholar
• Sass P, Bierbaum G. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 2007; 73:347 - 352
   PubMed Web of Science ®Google Scholar
• Loessner MJ, Gaeng S, Wendlinger G, Maier SK, Scherer S. The two-component lysis system of Staphylococcus aureus bacteriophage twort: a large TTG-start holin and an associated amidase endolysin. FEMS Microbiol Lett 1998; 162:265 - 274
   PubMed Web of Science ®Google Scholar
• Cheng Q, Fischetti VA. Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci. Appl Microbiol Biotechnol 2007; 74:1284 - 1291
   PubMed Web of Science ®Google Scholar
• Horgan M, O'Flynn G, Garry J, Cooney J, Coffey A, Fitzgerald GF, et al. The phage lysin, LysK, can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol 2009; 75:872 - 874
   PubMed Web of Science ®Google Scholar
• Low LY, Yang C, Perego M, Osterman A, Liddington RC. Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem 2005; 280:35433 - 35439
   PubMed Web of Science ®Google Scholar
• Briers Y, Schmelcher M, Loessnen MJ, Hendrix J, Engelborghs Y, Volckaert G, et al. The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144. Biochem Biophys Res Commun 2009; 383:187 - 191
   PubMed Web of Science ®Google Scholar
• Cheng X, Zhang X, Pflugrath JW, Studier FW. The structure of bacteriophage T7 lysozyme, a zinc amidase and an inhibitor of T7 RNA polymerase. Proc Natl Acad Sci USA 1994; 91:4034 - 4038
   PubMed Web of Science ®Google Scholar
• Sagermann M, Matthews BW. Crystal structures of a T4-lysozyme duplication-extension mutant demonstrate that the highly conserved beta-sheet region has low intrinsic folding propensity. J Mol Biol 2002; 316:931 - 940
   PubMed Web of Science ®Google Scholar
• Korndorfer IP, Danzer J, Schmelcher M, Zimmer M, Skerra A, Loessner MJ. The crystal structure of the bacteriophage PSA endolysin reveals a unique fold responsible for specific recognition of Listeria cell walls. J Mol Biol 2006; 364:678 - 689
   PubMed Web of Science ®Google Scholar
• Porter CJ, Schuch R, Pelzek AJ, Buckle AM, McGowan S, Wilce MC. The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis. J Mol Biol 2007; 366:540 - 550
   PubMed Web of Science ®Google Scholar
• Alcantara EH, Kim DH, Do SI, Lee SS. Bi-functional activities of chimeric lysozymes constructed by domain swapping between bacteriophage T7 and K11 lysozymes. J Biochem Mol Biol 2007; 40:539 - 546
   PubMedGoogle Scholar
• Croux C, Ronda C, Lopez R, Garcia JL. Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme. Mol Microbiol 1993; 9:1019 - 1025
   PubMed Web of Science ®Google Scholar
• Sanz JM, Garcia P, Garcia JL. Construction of a multifunctional pneumococcal murein hydrolase by module assembly. Eur J Biochem 1996; 235:601 - 605
   PubMedGoogle Scholar
• Sheehan MM, Garcia JL, Lopez R, García P. Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling. FEMS Microbiol Lett 1996; 140:23 - 28
   PubMed Web of Science ®Google Scholar
• Hanlon J. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. J Anti Microbial agents 2007; 30:118 - 128
   PubMed Web of Science ®Google Scholar
• Jado I, Lopez R, Garcia E, Fenoll A, Casal J, Garcia P. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 2003; 52:967 - 973
   PubMed Web of Science ®Google Scholar
• Loeffler JM, Djurkovic S, Fischetti VA. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 2003; 71:6199 - 6204
   PubMed Web of Science ®Google Scholar
• McCullers JA, Karlstrom A, Iverson AR, Loeffler JM, Fischetti VA. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog 2007; 3:28
   PubMed Web of Science ®Google Scholar
• Fischetti VA. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbial 2005; 13:496
   Google Scholar
• Entenza JM, Loeffler JM, Grandgirard D, Fischetti VA, Moreillon P. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother 2005; 49:4789 - 4792
   PubMed Web of Science ®Google Scholar
• Walsh S, Shah A, Mond J. Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. Antimicrob Agents Chemother 2003; 47:554 - 558
   PubMed Web of Science ®Google Scholar
• Garcia P, Lopez R, Ronda C, Garcia E, Tomasz A. Mechanism of phage induced lysis in pneumococci. J Gen Microbiol 1983; 129:479 - 487
   PubMedGoogle Scholar
• Fischetti VA. Novel method to control pathogenic bacteria on human mucous membranes. Ann N Y Acad Sci 2003; 987:207 - 214
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Shibata Y, Nakano Y, Tsuda H, Kido N, Ohta M, et al. A novel gene required for rhamnose-glucose polysaccharide synthesis in Streptococcus mutans. J Bacteriol 1999; 181:6556 - 6559
   PubMed Web of Science ®Google Scholar
• Becker SC, Foster-Frey J, Donovan DM. The phage K enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbial Lett 2008; 287:185 - 191
   PubMed Web of Science ®Google Scholar
• Loffler JM, Fischetti VA. Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother 2003; 47:375 - 377
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cerrato V, Garcia P, Del Prado G, Garcia E, Gracia M, Huelves L, et al. In vitro actions of LytA, the major pneumococcal autolysin. With two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. J Antimicrob Chemother 2007; 60:1159 - 1162
   PubMed Web of Science ®Google Scholar
• Djurkovic S, Loeffler JM, Fischetti VA. Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. J Antimicrob Chemother 2005; 49:1225 - 1228
   Web of Science ®Google Scholar
• Cheng Q, Nelson D, Zhu Z. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother 2005; 49:111 - 117
   PubMed Web of Science ®Google Scholar
• Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, et al. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother 2005; 11:211 - 219
   PubMed Web of Science ®Google Scholar
• Brown PD, Lerner SA. Community-acquired pneumonia. Lancet 1998; 352:1295 - 1302
   PubMed Web of Science ®Google Scholar
• Witzenrath M, Schmeck B, Doehn JM, Tschernig T, Zahlten J, Loeffler JM, et al. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Crit Care Med 2009; 37:779 - 780
   PubMed Web of Science ®Google Scholar
• Grandgirard D, Loeffler JM, Fischetti VA, Leib SL. Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J Infect Dis 2008; 197:1519 - 1522
   PubMed Web of Science ®Google Scholar
• Cheng Q, Fischetti VA. Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci. Appl Microbial Biotechnol 2006; 74:1284 - 1291
   PubMed Web of Science ®Google Scholar
• Gruet P, Maicent P, Berthelot X, Kaltsatos V. Bovine mastitis and intramammary drug delivery: review and perspectives. Adv Drug Deliv Rev 2001; 50:245 - 259
   PubMed Web of Science ®Google Scholar
• European Antimicrobial Resistance Surveillance System (EARSS) management team, members of the advisory board, and national representatives of EARSS 2007. EARSS annual report 2006 The Netherlands EARSS, Bilthoven
   Google Scholar
• Eady AE, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus—an emerging problem for the management of skin and soft tissue infections. Curr Opin Infectious Dis 2003; 16:103 - 124
   PubMed Web of Science ®Google Scholar
• Obeso JM, Martinez B, Rodriguez A, Garcia P. Lytic activity of the recombinant staphylococcal bacteriophage phiH5 endolysin active against Staphylococcus aureus in milk. Int J Food Microbiol 2008; 128:211 - 218
   Web of Science ®Google Scholar
• Donovan DM, Lardeo M, Foster-Frey J. Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbial Lett 2006; 265:133 - 139
   PubMed Web of Science ®Google Scholar
• Sass P, Bierbaum G. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 2007; 73:347 - 352
   PubMed Web of Science ®Google Scholar
• Yoong P, Schuch R, Nelson D, Fischetti VA. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J Bacteriol 2004; 186:4808 - 4812
   PubMed Web of Science ®Google Scholar
• Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Asher MS, Eitzen E. Anthrax as a biological weapon 2002: updated recommendations for management. JAMA 2002; 287:2236 - 2252
   PubMed Web of Science ®Google Scholar
• Yoong P, Schuch R, Nelson D, Fischetti VA. PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J Bacteriol 2006; 188:2711 - 2714
   PubMed Web of Science ®Google Scholar
• Dancer SJ. How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infect Dis 2004; 4:611 - 619
   PubMed Web of Science ®Google Scholar
• Mayer MJ, Narbad A, Gasson MJ. Molecular characterisation of Clostridium difficile bacteriophage and its cloned biologically active endolysin. J Bacteriol 2008; 20:6734 - 6740
   Web of Science ®Google Scholar
• Byrnestad S, Synstad B, Granum PR. The Clostridium perfringens enterotoxin gene is a transposable element in type A human food poisoning strains. Microbiology 1997; 143:2109 - 2115
   PubMed Web of Science ®Google Scholar
• Zimmer M, Vukov N, Scherer S, Loessner MJ. The murien hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl Environ Microbiol 2002; 68:5311 - 5317
   PubMed Web of Science ®Google Scholar
• Courchesne NM, Parisien A, Lan CQ. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat Biotechnol 2009; 3:37 - 45
   PubMedGoogle Scholar
• Wellenberg GJ, van der Poel WH, Van Oirschot JT. Viral infections and bovine mastitis: a review. Vet Microbiol 2002; 88:27 - 45
   PubMed Web of Science ®Google Scholar
• Celia LK, Nelson D, Kerr DE. Characterisation of a bacteriophage lysin (Ply700) from Streptococcus uberis. Vet Microbiol 2007; 130:107 - 117
   PubMed Web of Science ®Google Scholar
• Lun ZR, Wang QP, Chen QG, Li AX, Zhu XQ. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis 2007; 7:201 - 209
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun JH, Lu CP. Purified phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci. J Curr Microbiol 2009; 58:609 - 615
   PubMed Web of Science ®Google Scholar
• Zhang C, Ning Y, Zhang Z, Song L, Qui H, Gao H. In vitro antimicrobial susceptibility of Streptococcus suis strains isolated from clinically healthy sows in China. Vet Microbiol 2008; 131:386 - 392
   PubMed Web of Science ®Google Scholar
• Hoopes JT, Stark CJ, Kim HA, Sussman DJ, Donovan MD, Nelson DC. Use of a bacteriophage lysin, PlyC as an enzyme disinfectant against Streptococcus equi. Appl Environ Microbiol 2009; 1388 - 1394
   PubMed Web of Science ®Google Scholar
• Sweeney CR, Whitlock RH, Meirs DA, Whitehead SC, Barningham SO. Complications associated with Streptococcus equi infection on a horse farm. J Am Vet Med Assoc 1987; 191:1446 - 1448
   PubMed Web of Science ®Google Scholar
• Gaeng S, Scherer S, Neve H, Loessner MJ. Gene cloning and expression and secretion of Listeria monocytogenes bacteriophage-lytic enzymes in Lactococcus lactis. Appl Environ Microbiol 2000; 66:2951 - 2958
   PubMed Web of Science ®Google Scholar
• de Ruyter PGGA, Kuipers OP, Meijer WC, de Vos VM. Food-grade controlled lysis of Lactococcus lactis for accelerated cheese ripening. Nat Biotechnol 1997; 15:976 - 979
   PubMed Web of Science ®Google Scholar
• During K, Porsch P, Fladung M, Lörz H. Transgenic potato plants resistant to the phytopathogenic bacterium Erwinia carotovora. Plant J 1993; 3:587 - 598
   Web of Science ®Google Scholar
• Kim WS, Salm H, Geider K. Expression of bacteriophage ϕEa1h lysozyme in Escherichia coli and its activity in growth inhibition of Erwinia amylovora. Microbiology 2004; 150:2707 - 2714
   PubMed Web of Science ®Google Scholar
• During K, Porsch P, Mahn A, Brinkmann O, Gieffers W. The non enzymatic microbicidal activity of lysozymes. FEBS Lett 1999; 449:93 - 100
   PubMed Web of Science ®Google Scholar
• Rosovitz MJ, Leppla SH. Virus deals anthrax a killer blow. Nature 2002; 418:825 - 826
   PubMed Web of Science ®Google Scholar
• Kretzer JW, Lehmann R, Schmelcher M, Banz M, Kim KP, Korn C, et al. Use of high-affinity cell wall-binding domains of bacteriophage endolysins for immobilization and separation of bacterial cells. Appl Environ Microbiol 2007; 73:1992 - 2000
   PubMed Web of Science ®Google Scholar
• Koller T, Nelson D, Nakata M, Kreutzer M, Fischetti VA, Glocker MO. PlyC, a novel enzyme for compartment dependent proteomics of group A Streptococci. Proteomics 2007; 8:140 - 148
   Web of Science ®Google Scholar
• Pritchard DG, Dong S, Baker JR, Engler EA. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 2004; 150:2079 - 2087
   PubMed Web of Science ®Google Scholar
• Pritchard DG, Dong S, Kirk MC, Cartee RT, Baker JR. LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl Environ Microbiol 2007; 73:7150 - 7154
   PubMed Web of Science ®Google Scholar
• Takac M, Witte A, Blasi U. Functional analysis of the lysis genes of Staphylococcus aureus phage P68 in Escherichia coli. Microbiology 2005; 151:2331 - 2342
   PubMed Web of Science ®Google Scholar
• Yokoi KJ, Kawahigashi N, Uchida M, Sugahara K, Shinohara M, Kawasaki KI. The two component cell lysis genes holWMY and lysWMY of the Staphylococcus warneri M phage WMY: cloning, sequencing, expression and mutational analysis in Escherichia coli. Gene 2005; 351:97 - 108
   PubMed Web of Science ®Google Scholar
• Delisle AL, Barcak GJ, Guo M. Isolation and expression of the lysis genes of Actinomyces naeslundii phage Av-1. Appl Environ Microbiol 2006; 72:1110 - 1117
   PubMed Web of Science ®Google Scholar
• Sugahara K, Yokai KJ, Nakamura Y, Nishino T, Yamakawa A, Taketo A. Mutational and biochemical analysis of the endolysin LysgaY encoded by the Lactobacillus gasseri JCM phage Φ gaY. Gene 2007; 404:41 - 52
   PubMed Web of Science ®Google Scholar